The SS18L1 gene has been implicated in a range of neurological conditions, including Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The genetic test focusing on the SS18L1 gene's involvement in ALS, particularly in relation to the CREST syndrome - a complex disorder that can include calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia - provides crucial insights for individuals with a family history of ALS or related symptoms.
DNA Labs UAE offers a specialized genetic test targeting the SS18L1 gene to identify mutations that may contribute to the development of ALS and its overlap with CREST-related symptoms. This test is essential for patients seeking a comprehensive understanding of their genetic predisposition to ALS and CREST syndrome, allowing for early intervention, personalized treatment plans, and informed family planning.
The cost of this comprehensive genetic test is 4400 AED. Conducted at DNA Labs UAE, the test involves a simple procedure but offers profound insights into the patient's genetic makeup, potentially guiding crucial health decisions and lifestyle adjustments to manage or mitigate the risk of ALS and related conditions.
The NEFH gene, known for its role in encoding the heavy neurofilament protein, has been linked to susceptibility to Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease affecting nerve cells in the brain and the spinal cord. Genetic testing focused on the NEFH gene can provide crucial insights into an individual's risk of developing ALS, allowing for early intervention and personalized management strategies.
At DNA Labs UAE, a specialized test is available to assess the genetic variations in the NEFH gene that might increase susceptibility to ALS. The test, priced at 4400 AED, involves a comprehensive analysis of the NEFH gene to identify mutations that could indicate a higher risk of developing this debilitating condition. By opting for this genetic test, individuals can gain valuable information about their genetic predisposition to ALS, enabling them to make informed decisions about their health and future.
The VPS54 gene has been identified as a potential contributor to the development of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The VPS54-related genetic test is a specialized diagnostic tool designed to detect mutations in the VPS54 gene, which may indicate an increased risk or presence of ALS in individuals. This test is particularly useful for those with a family history of ALS or related symptoms, providing crucial information for early diagnosis and potential management of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the VPS54 gene test is performed with high precision and accuracy. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. By opting for this test, individuals can gain valuable insights into their genetic predisposition towards ALS, enabling them to make informed decisions regarding their health and future care plans.
The APP Gene Alzheimer Disease Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the APP gene, which are strongly linked to the early onset of Alzheimer's disease. Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. The APP gene encodes the amyloid precursor protein, and mutations in this gene can lead to the abnormal accumulation of amyloid-beta peptides in the brain, a hallmark of Alzheimer's disease.
This genetic test is particularly important for individuals with a family history of early-onset Alzheimer's disease, as it can provide crucial information regarding their risk of developing the condition. Early detection through genetic testing allows for timely intervention and management strategies to slow the progression of the disease and improve the quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services. The cost of the APP Gene Alzheimer Disease Type 1 Genetic Test is 4400 AED. The testing process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the APP gene. The results of this test can guide healthcare professionals in developing personalized care plans for individuals at risk or affected by Alzheimer's disease, focusing on managing symptoms and providing support for the patient and their family.
The NOS3 gene, also known as the endothelial nitric oxide synthase (eNOS) gene, plays a crucial role in vascular function and has been implicated in various cardiovascular diseases. Recent studies suggest that variations in the NOS3 gene may also be linked to Alzheimer's disease type 1, a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and behavioral changes. The association is thought to be due to the gene's impact on blood flow and nutrient delivery to the brain, influencing the development and progression of Alzheimer's disease.
To explore this genetic link further, DNA Labs UAE offers a specialized genetic test targeting the NOS3 gene in relation to Alzheimer's disease type 1. This test is designed to identify specific mutations or variations within the NOS3 gene that may increase an individual's risk of developing Alzheimer's disease. By analyzing a sample of the patient's DNA, the test can provide valuable insights into their genetic predisposition to this condition.
The cost of the NOS3 Gene Alzheimer Disease Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full testing procedure, from sample collection to detailed analysis and reporting. Patients who opt for this test can expect a comprehensive evaluation of their genetic risk factors for Alzheimer's disease, enabling them to make informed decisions about their health and potential preventive measures. It's an essential tool for those with a family history of Alzheimer's disease or individuals seeking to understand their genetic health profile better.
The ADAM10 gene plays a significant role in the susceptibility to Alzheimer's disease type 18, a form of the condition that has a genetic underpinning. This particular gene is involved in the cellular processes that can influence the development of Alzheimer's disease, making its study crucial for understanding individual risks and potential therapeutic targets.
Genetic testing for the ADAM10 gene's involvement in Alzheimer's disease type 18 susceptibility offers a proactive approach for individuals concerned about their risk of developing this neurodegenerative disorder. Conducted at DNA Labs UAE, this specialized test aims to identify specific genetic markers associated with an increased risk of Alzheimer's disease, providing valuable insights into one's genetic predisposition.
The test is priced at 4400 AED, reflecting the comprehensive analysis and personalized assessment it offers. By opting for this test, individuals can gain crucial information on their genetic makeup, empowering them with the knowledge to make informed decisions regarding their health and potential preventive measures against Alzheimer's disease.
The APOE gene Alzheimer's disease type 2 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify the presence of specific alleles of the APOE gene that are associated with an increased risk of developing Alzheimer's disease. The APOE gene is instrumental in the metabolism of fats in the body and has three common alleles: ε2, ε3, and ε4. The ε4 allele is linked to a higher risk of Alzheimer's disease, while the ε2 allele is considered to provide some protection against the condition.
This test is crucial for individuals with a family history of Alzheimer's disease or those who wish to understand their genetic predisposition to this neurodegenerative disorder. It involves a simple sample collection process, after which the DNA is analyzed to determine the specific APOE alleles present.
The cost of the APOE gene Alzheimer's disease type 2 genetic test at DNA Labs UAE is 4400 AED. This price includes the full testing procedure and a comprehensive report that explains the results and their implications for the individual's risk of developing Alzheimer's disease. It's an invaluable tool for those seeking early intervention strategies or simply peace of mind regarding their genetic health.
The "PSEN1 Gene Alzheimer Disease Type 3 Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the PSEN1 gene, which are linked to an increased risk of developing early-onset Alzheimer's disease, also known as Alzheimer disease type 3. This form of Alzheimer's disease is hereditary and tends to manifest at a younger age, typically before the age of 65. The PSEN1 gene plays a crucial role in the production of a protein that is part of the process that leads to the accumulation of amyloid plaques, a hallmark of Alzheimer's disease.
Conducted at DNA Labs UAE, this genetic test is a vital tool for individuals with a family history of early-onset Alzheimer's disease, providing them with crucial information regarding their genetic predisposition to the condition. By undergoing this test, individuals can make informed decisions about their future health and lifestyle, and in some cases, take preventative measures or plan for early intervention.
The cost of the PSEN1 Gene Alzheimer Disease Type 3 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the testing procedure, analysis, and comprehensive reporting. Given the specialized nature of this test and its significance in potentially altering the course of one's life, the cost reflects the value of advanced genetic insights into one's health.
The PSEN2 Gene Alzheimer's Disease Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PSEN2 gene, which are linked to the development of Alzheimer's disease type 4. This form of Alzheimer's disease is inherited in an autosomal dominant pattern, meaning a mutation in just one copy of the gene in each cell is sufficient to increase an individual's risk of developing the condition. The test is crucial for individuals with a family history of Alzheimer's disease, as it can provide valuable insights into their genetic predisposition to this type of dementia.
The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic variations in the PSEN2 gene that are associated with Alzheimer's disease type 4. The results of this test can help individuals make informed decisions about their health and lifestyle, and in some cases, may lead to the consideration of preventative measures or early interventions.
The cost of the PSEN2 Gene Alzheimer's Disease Type 4 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specific expertise required to conduct and interpret the test, this price reflects the comprehensive service provided, including the genetic counseling that is often recommended to discuss the results and their implications for the individual and their family members.
The SORL1 gene, associated with early-onset Alzheimer's disease, is a focus of genetic testing aimed at identifying individuals at risk of developing this autosomal dominant form of Alzheimer's. This specific form of the disease manifests earlier than the more common late-onset Alzheimer's, often affecting individuals before the age of 65. The SORL1 gene has been identified as a significant player in the disease's pathology, influencing the processing of amyloid precursor protein, which is crucial in the development of amyloid plaques—a hallmark of Alzheimer's disease.
DNA Labs UAE offers a comprehensive genetic test targeting the SORL1 gene to determine an individual's risk of developing early-onset Alzheimer's disease. The test, priced at 4400 AED, involves a detailed analysis of the SORL1 gene to identify mutations that are known to contribute to the development of Alzheimer's disease. This predictive testing is particularly valuable for individuals with a family history of early-onset Alzheimer's, providing them with crucial information regarding their genetic predisposition to the disease.
By opting for this test, individuals can gain insights into their genetic makeup, allowing them to make informed decisions about their health and future. The results can also guide healthcare professionals in tailoring prevention strategies and early intervention plans, potentially mitigating the impact of the disease. DNA Labs UAE ensures confidentiality and accuracy, offering support and guidance throughout the testing process.
